Overall Status

Completed (57)

Recruiting (15)

Not yet recruiting (13)

Unknown status (7)

Active, not recruiting (5)

Terminated (4)

Withdrawn (3)

Enrolling by invitation (1)

Phase

n/a (64)

phase 1 (7)

phase 1/phase 2 (7)

phase 2 (7)

phase 4 (6)

phase 3 (4)

early phase 1 (2)

phase 2/phase 3 (2)

Study Documents

Intervention Type

dietary supplement (45)

other (33)

drug (28)

procedure (5)

behavioral (3)

biological (3)

device (3)

diagnostic test (3)

combination product (1)

Funder Type

Other (90)

Industry (12)

U.S. Fed (2)

NIH (1)

Study Type

Interventional (99)

Observational (6)

mushroom

Showing 101 - 105 of 105

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Healthy Trial in Bergen (lentinan, )

Unknown status

Healthy

lentinan
placebo

Bergen, Paradis, Norway

Centre for clinical studies

May 12, 2008

HIV, Hyperlipidemia Trial in San Francisco (oyster mushroom)

Completed

HIV Infections
Hyperlipidemia

oyster mushroom

San Francisco, California

General Clinical Research Center, San Francisco General Hospital

Sep 25, 2007

Asthma Trial in Hong Kong (CUF2, Placebo)

Completed

Asthma

CUF2
Placebo

Hong Kong, Hong Kong
+1 more

Mar 11, 2008

Pediatric Cancers Trial in Hong Kong (LingZhi capsule)

Completed

Pediatric Cancers

LingZhi capsule

Hong Kong, Hong Kong
+2 more

Dec 17, 2007

Allergic Conjunctivitis Trial in Kyoto (beta-1,3-glucan)

Terminated

Allergic Conjunctivitis

beta-1,3-glucan

Kyoto, Japan

Meiji University of Oriental Medicine

Nov 6, 2006